Applied Proteomics Snags $22.5M in Funding; Aims to Optimize Mass Spec-Based Biomarker Discovery
February 10, 2012
Applied Proteomics Snags $22.5M in Funding; Aims to Optimize Mass Spec-Based Biomarker Discovery
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- GenomeWeb Feature: The Unsteady March of Cancer Protein Biomarkers into the Clinic
May 10, 2013 / ProteoMonitor - Changing Course, Applied Proteomics to Offer Colon Test via Mass Spec Instead of Immunoassay
March 29, 2013 / ProteoMonitor - Targeted Mass Spec Slowly but Steadily Moving Toward Broader Commercial, Clinical Adoption
September 21, 2012 / ProteoMonitor - Calling for Stronger Clinical Focus, Researchers Question Priorities of NCI's CPTAC Initiative
February 17, 2012 / ProteoMonitor - People in the News: New Board Member, CEO at Applied Proteomics
February 10, 2012 / ProteoMonitor